ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Chromatin Accessibility Mapping Software for Target Validation and Hit Identification
An integrated bioinformatics software suite that analyzes ATAC-seq and ChIP-seq data to map chromatin landscapes and validate epigenetic drug targets in real-time. The platform monetizes through per-sample processing fees and enterprise licensing agreements with biotech companies.
Epigenetic Drug Target Identification Platforms Click to view more details →
Non-Coding RNA Epigenetic Target Discovery Engine for Oncology Programs
A proprietary analytics engine that identifies dysregulated non-coding RNAs as druggable epigenetic targets by integrating transcriptomic and epigenomic datasets. This service creates premium revenue streams through tiered subscription models and research collaboration partnerships.
Epigenetic Drug Target Identification Platforms Click to view more details →
Histone Deacetylase and Methyltransferase Inhibitor Screening Platform
A high-throughput screening platform that systematically identifies and ranks HDAC and methyltransferase inhibitors against disease-specific epigenetic signatures. The tool generates revenue through compound screening services, assay licensing, and data analytics subscriptions for pharma clients.
Epigenetic Drug Target Identification Platforms Click to view more details →
Epigenetic Biomarker Validation SaaS for Clinical Trial Patient Stratification
A cloud-based diagnostic service that validates epigenetic biomarkers and predicts patient response to epigenetic drugs in clinical trial cohorts. This platform captures value through per-patient testing fees, real-time trial monitoring subscriptions, and biomarker licensing agreements.
Epigenetic Drug Target Identification Platforms Click to view more details →
Polycomb Group Protein Target Identification and Validation Toolkit
A specialized bioinformatics toolkit that maps Polycomb-repressive complex activity to identify novel cancer vulnerabilities and druggable epigenetic nodes. This commercial offering generates revenue through software licensing, professional services consultation, and partnerships with precision medicine companies.
Epigenetic Drug Target Identification Platforms Click to view more details →
Spatial Epigenomics Platform for Tumor Heterogeneity and Resistance Mapping
An integrated platform combining spatial genomics with epigenomic analysis to map epigenetic heterogeneity within tumors and identify resistance mechanisms. This service model generates recurring fees through sample processing, data analysis subscriptions, and exclusive research partnerships with oncology focused firms.
Epigenetic Drug Target Identification Platforms Click to view more details →
Multi-Omics Epigenetic Integration Engine for Personalized Drug Target Prediction
A comprehensive SaaS platform that integrates epigenomic, transcriptomic, and proteomic data to predict personalized epigenetic drug targets for individual patients. The platform monetizes through API access fees, per-analysis licensing, and white-label deployment for healthcare and biotech enterprises.
Epigenetic Drug Target Identification Platforms Click to view more details →
Bromodomain and Extraterminal Protein Inhibitor Discovery and Optimization Platform
A specialized drug discovery platform that accelerates identification and optimization of BET protein inhibitors and related epigenetic modulators through structure-guided design. This service generates revenue through contract research agreements, technology licensing, and royalties on commercialized therapeutic candidates.
Epigenetic Drug Target Identification Platforms Click to view more details →
High-Throughput Bisulfite Sequencing Analysis Platform
A cloud-based SaaS platform that automates processing and analysis of whole-genome bisulfite sequencing data with machine learning-powered quality control and methylation pattern detection. Generates premium reports for pharmaceutical companies and research institutions, enabling subscription-based revenue streams and per-sample processing fees.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Real-Time Methylation Pattern Recognition Engine
An AI-driven commercial service that identifies disease-associated methylation signatures in real-time across multiple tissue types using proprietary deep learning algorithms. Delivers monetizable biomarker discovery and validation services for oncology, neurology, and metabolic disease segments.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Enterprise DNA Methylation Data Integration Hub
A secure, HIPAA-compliant enterprise platform consolidating methylation data from diverse sources with standardized formatting and cross-sample normalization capabilities. Provides white-label solutions and managed services contracts generating recurring revenue from clinical genomics labs and hospitals.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Predictive Epigenetic Biomarker Discovery Workflow
A commercial computational pipeline that correlates methylation patterns with clinical outcomes to identify novel disease biomarkers for pharmaceutical partner organizations. Monetizes through licensing agreements, milestone payments, and royalties on biomarker-based diagnostic development.
DNA Methylation Analysis Service Platform Dev Click to view more details →